1 active not recruiting, 1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Long Qt Syndrome 2: new trials by email Literature Review of Long Qt Syndrome 2 trials Research Report on Long Qt Syndrome 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Observational Study to Describe Health-Related Quality of Life and Measure Disease Burden Among Patients With Long QT Syndrome Types (LQTS) 2 and 3 Long QT Syndrome Type 3, Long QT Syndrome 2 | Active not recruiting | Thryv Therapeutics, Inc. | 200 | 2025-10-27 | 2026-10-08 | |
| Study to Evaluate the Effect of Eleclazine on QT, Safety, and Tolerability in Participants With Long QT2 Syndrome Eleclazine, Placebo - LQT2 Syndrome | Phase 1 | Completed | Gilead Sciences | 13 | 2015-07-20 | 2020-12-30 |
Death, Sudden, Cardiac (1) · Long QT syndrome type 3 (1)
Cardiovascular Diseases (1) · Death (1) · Death, Sudden (1) · Heart Arrest (1) · Heart Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
eleclazine (1)
Gilead Sciences (1) · Thryv Therapeutics, Inc. (1)
United States (2)